Literature DB >> 6850642

Effect of size on portal circulation of hepatic nodules from carcinogen-treated rats.

J G Conway, J A Popp, S Ji, R G Thurman.   

Abstract

The portal circulation of diethylnitrosamine-initiated nodules (0.5 to 7 mm in diameter) was studied in rat livers perfused exclusively via the portal vein. Microlight guides were placed on normal and nodular tissue on the capsular surface of the liver to measure pyridine nucleotide fluorescence (366 leads to 450 nm). When oxygen tension of the inflow perfusate was lowered, fluorescence in both normal tissue and small nodules (less than 2 mm in diameter) increased sharply due to the reduction of pyridine nucleotides, indicating previous normoxia. In contrast, similar manipulations did not increase fluorescence in nodules greater than 2 mm in diameter, demonstrating that nicotinamide adenine dinucleotide was reduced maximally previously; i.e., the nodules were anoxic. Direct measurements of nodule oxygen concentrations with a miniature oxygen electrode confirmed these results. 7-Hydroxycoumarin or fluorescein could be detected with micro-light guides in normal tissue and nodules less than 2 mm in diameter but not in nodules greater than 2 mm in diameter. Furthermore, fluorescent microscopy indicated an absence of fluorescein in nodules greater than 2 mm in diameter. Therefore, with four independent optical and polarographic techniques, we have demonstrated reduced portal circulation in nodules greater than 2 mm in diameter; however, smaller nodules could not be differentiated from normal tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6850642

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer.

Authors:  Sotaro Sadahiro; Toshiyuki Suzuki; Akira Tanaka; Kazutake Okada; Hiroko Kamata; Jun Koisumi
Journal:  Surg Today       Date:  2012-11-10       Impact factor: 2.549

Review 2.  Liver cell models in in vitro toxicology.

Authors:  A Guillouzo
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

3.  The significance of portal vein chemotherapy for liver micrometastases: an experimental study of a rat model.

Authors:  H Ishida; T Iwama; Y Mishima
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

4.  Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study.

Authors:  Yao Wang; Xin Rong Sun; Wen Ming Feng; Ying Bao; Yin Yuan Zheng
Journal:  Onco Targets Ther       Date:  2016-09-26       Impact factor: 4.147

5.  Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy.

Authors:  Min Feng; Chengwu Tang; Wenming Feng; Ying Bao; Yinyuan Zheng; Jianbin Shen
Journal:  Onco Targets Ther       Date:  2017-06-14       Impact factor: 4.147

6.  Postoperative hepatic arterial infusion chemotherapy improved survival of pancreatic cancer after radical pancreatectomy: a retrospective study.

Authors:  Yongchun Wang; Yongqiang Xu; Yinyuan Zheng; Ying Bao; Ping Wang
Journal:  Onco Targets Ther       Date:  2018-02-21       Impact factor: 4.147

7.  Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats.

Authors:  T Ikebe; T Yamamoto; S Kubo; K Hirohashi; H Kinoshita; K Kaneda; M Sakurai
Journal:  Jpn J Cancer Res       Date:  1998-02

8.  Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases.

Authors:  L H Ramirez; J N Munck; C Bognel; Z Zhao; P Ardouin; M F Poupon; A Gouyette; P Rougier
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

9.  Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection.

Authors:  Cheng Chen; Wenming Feng; Yinyuan Zheng; Ying Bao; Min Feng
Journal:  Onco Targets Ther       Date:  2018-05-22       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.